栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/02/18 | 2,300 | 2,318 | 2,236 | 2,243 | -17 | -0.8% | 130,300 |
2025/02/17 | 2,252 | 2,283 | 2,248 | 2,260 | +10 | +0.4% | 93,400 |
2025/02/14 | 2,221 | 2,252 | 2,221 | 2,250 | +69 | +3.2% | 174,300 |
2025/02/13 | 2,162 | 2,189 | 2,158 | 2,181 | +56 | +2.6% | 78,000 |
2025/02/12 | 2,145 | 2,145 | 2,107 | 2,125 | -20 | -0.9% | 83,800 |
2025/02/10 | 2,140 | 2,161 | 2,135 | 2,145 | +5 | +0.2% | 76,500 |
2025/02/07 | 2,142 | 2,183 | 2,135 | 2,140 | -2 | -0.1% | 85,600 |
2025/02/06 | 2,170 | 2,178 | 2,141 | 2,142 | -1 | ±0% | 84,700 |
2025/02/05 | 2,123 | 2,171 | 2,123 | 2,143 | +53 | +2.5% | 137,900 |
2025/02/04 | 2,150 | 2,174 | 2,075 | 2,090 | -73 | -3.4% | 239,500 |
2025/02/03 | 2,150 | 2,184 | 2,137 | 2,163 | +25 | +1.2% | 148,800 |
2025/01/31 | 2,151 | 2,160 | 2,123 | 2,138 | -13 | -0.6% | 126,200 |
2025/01/30 | 2,148 | 2,159 | 2,140 | 2,151 | +12 | +0.6% | 96,700 |
2025/01/29 | 2,177 | 2,177 | 2,139 | 2,139 | -22 | -1% | 100,400 |
2025/01/28 | 2,164 | 2,175 | 2,154 | 2,161 | -31 | -1.4% | 111,200 |
2025/01/27 | 2,188 | 2,197 | 2,170 | 2,192 | +6 | +0.3% | 72,400 |
2025/01/24 | 2,169 | 2,199 | 2,169 | 2,186 | +23 | +1.1% | 66,700 |
2025/01/23 | 2,151 | 2,172 | 2,151 | 2,163 | +3 | +0.1% | 56,100 |
2025/01/22 | 2,179 | 2,179 | 2,149 | 2,160 | +10 | +0.5% | 49,300 |
2025/01/21 | 2,153 | 2,161 | 2,145 | 2,150 | -1 | ±0% | 96,700 |
2025/01/20 | 2,163 | 2,180 | 2,151 | 2,151 | +3 | +0.1% | 81,500 |
2025/01/17 | 2,143 | 2,164 | 2,143 | 2,148 | +1 | ±0% | 88,400 |
2025/01/16 | 2,151 | 2,163 | 2,144 | 2,147 | -4 | -0.2% | 104,200 |
2025/01/15 | 2,159 | 2,187 | 2,146 | 2,151 | -5 | -0.2% | 126,800 |
2025/01/14 | 2,143 | 2,170 | 2,142 | 2,156 | +3 | +0.1% | 105,600 |
2025/01/10 | 2,150 | 2,166 | 2,145 | 2,153 | -9 | -0.4% | 79,200 |
2025/01/09 | 2,151 | 2,170 | 2,147 | 2,162 | -1 | ±0% | 97,700 |
2025/01/08 | 2,179 | 2,185 | 2,154 | 2,163 | -16 | -0.7% | 82,200 |
2025/01/07 | 2,150 | 2,182 | 2,142 | 2,179 | +34 | +1.6% | 78,200 |
2025/01/06 | 2,178 | 2,199 | 2,143 | 2,145 | ±0 | ±0% | 150,100 |
2024/12/30 | 2,190 | 2,221 | 2,142 | 2,145 | -20 | -0.9% | 98,300 |
2024/12/27 | 2,169 | 2,184 | 2,145 | 2,165 | -4 | -0.2% | 134,000 |
2024/12/26 | 2,192 | 2,194 | 2,157 | 2,169 | -23 | -1% | 122,500 |
2024/12/25 | 2,206 | 2,211 | 2,164 | 2,192 | -19 | -0.9% | 81,900 |
2024/12/24 | 2,257 | 2,269 | 2,203 | 2,211 | -13 | -0.6% | 131,800 |
2024/12/23 | 2,180 | 2,242 | 2,175 | 2,224 | +74 | +3.4% | 180,100 |
2024/12/20 | 2,173 | 2,185 | 2,150 | 2,150 | -23 | -1.1% | 138,900 |
2024/12/19 | 2,156 | 2,197 | 2,150 | 2,173 | +17 | +0.8% | 149,500 |
2024/12/18 | 2,185 | 2,207 | 2,156 | 2,156 | -47 | -2.1% | 140,000 |
2024/12/17 | 2,200 | 2,222 | 2,179 | 2,203 | +17 | +0.8% | 100,000 |
2024/12/16 | 2,150 | 2,198 | 2,144 | 2,186 | +42 | +2% | 90,200 |
2024/12/13 | 2,102 | 2,165 | 2,095 | 2,144 | +7 | +0.3% | 174,400 |
2024/12/12 | 2,146 | 2,161 | 2,134 | 2,137 | -9 | -0.4% | 117,300 |
2024/12/11 | 2,187 | 2,190 | 2,141 | 2,146 | -53 | -2.4% | 153,600 |
2024/12/10 | 2,219 | 2,230 | 2,168 | 2,199 | +9 | +0.4% | 101,400 |
2024/12/09 | 2,145 | 2,204 | 2,145 | 2,190 | +45 | +2.1% | 113,100 |
2024/12/06 | 2,164 | 2,165 | 2,117 | 2,145 | -7 | -0.3% | 106,400 |
2024/12/05 | 2,150 | 2,165 | 2,126 | 2,152 | +29 | +1.4% | 74,800 |
2024/12/04 | 2,179 | 2,215 | 2,123 | 2,123 | -68 | -3.1% | 130,500 |
2024/12/03 | 2,187 | 2,224 | 2,181 | 2,191 | +4 | +0.2% | 120,100 |
51~
100
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
あすかHD | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム